Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Dyson

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Oncotarget|May 14, 2015
Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeuticsAliccia Bollig-Fischer, Sharon K Michelhaugh, Priyanga Wijesinghe, et al.
Carcinogenesis|January 1, 2016
Whole-exome sequencing reveals genetic variability among lung cancer cases subphenotyped for emphysemaChristine M Lusk, Angela S Wenzlaff, Greg Dyson, et al.
Cancer Research|August 18, 2018
IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor ImmunotherapyHeather M Gibson, Brooke N McKnight, Agnes Malysa, et al.
Journal of Cancer Survivorship : Research and Practice|December 21, 2025
The incidence of a second primary cancer diagnosis and impact on health-related quality of life in Black cancer survivorsJulie J Ruterbusch, Kathleen A Cooney, Tara E Baird, et al.
Scientific Reports|March 11, 2017
Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneityBin Bao, Cristina Mitrea, Priyanga Wijesinghe, et al.
American Journal of Cancer Research|November 13, 2018
The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancerGreg Dyson, Batoul Farran, Susan Bolton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 22, 2013
Genes associated with prostate cancer are differentially expressed in African American and European American menIsaac J Powell, Greg Dyson, Susan Land, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer PatientsChristine M Lusk, Donovan Watza, Greg Dyson, et al.
Journal for Immunotherapy of Cancer|March 27, 2026
Pharmacologic targeting of the dopamine D2 receptor impacts the efficacy of immune checkpoint blockade in melanomaMark Gregory, Justin B Hackett, Savannah Hughes, et al.
Gynecologic Oncology Reports|August 4, 2021
Impact of positive cytology in uterine serous carcinoma: A reassessmentLogan Corey, Juliana Fucinari, Mohamed Elshaikh, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Oncotarget|May 14, 2015
Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeuticsAliccia Bollig-Fischer, Sharon K Michelhaugh, Priyanga Wijesinghe, et al.
Carcinogenesis|January 1, 2016
Whole-exome sequencing reveals genetic variability among lung cancer cases subphenotyped for emphysemaChristine M Lusk, Angela S Wenzlaff, Greg Dyson, et al.
Cancer Research|August 18, 2018
IFNγ PET Imaging as a Predictive Tool for Monitoring Response to Tumor ImmunotherapyHeather M Gibson, Brooke N McKnight, Agnes Malysa, et al.
Journal of Cancer Survivorship : Research and Practice|December 21, 2025
The incidence of a second primary cancer diagnosis and impact on health-related quality of life in Black cancer survivorsJulie J Ruterbusch, Kathleen A Cooney, Tara E Baird, et al.
Scientific Reports|March 11, 2017
Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneityBin Bao, Cristina Mitrea, Priyanga Wijesinghe, et al.
American Journal of Cancer Research|November 13, 2018
The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancerGreg Dyson, Batoul Farran, Susan Bolton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 22, 2013
Genes associated with prostate cancer are differentially expressed in African American and European American menIsaac J Powell, Greg Dyson, Susan Land, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer PatientsChristine M Lusk, Donovan Watza, Greg Dyson, et al.
Journal for Immunotherapy of Cancer|March 27, 2026
Pharmacologic targeting of the dopamine D2 receptor impacts the efficacy of immune checkpoint blockade in melanomaMark Gregory, Justin B Hackett, Savannah Hughes, et al.
Gynecologic Oncology Reports|August 4, 2021
Impact of positive cytology in uterine serous carcinoma: A reassessmentLogan Corey, Juliana Fucinari, Mohamed Elshaikh, et al.
Pageof 4